Antioxidant Capacity and Vitamin A Profile in Young Adults Who Consume a Snack Bar Made From Tropical Fruits Treated With UV-C

April 27, 2018 updated by: Humberto Francisco Astiazaran Garcia, PhD, Centro de Investigación en Alimentación y Desarrollo A.C.

Antioxidant Capacity and Vitamin A Profile in Young Adults Who Consume a Snack Bar Made From Tropical Fruits Treated With UV-C.

The objective of the present study was to evaluate the impact of a snack bar on some health indicators associated with diet (plasma antioxidant capacity, lipid profile, vitamin A profile (retinol and carotenoids)) and on the nutritional status (impact on energy and nutrients consumed) in a group of upper level students.

Study Overview

Detailed Description

A blind randomized controlled clinical study of healthy adults, which was carried out with the approval of the ethics committee of the Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD, A.C.) with registration CE/001/2017. The intervention was carried out in a public university in Mexico from January to April 2017. Each subject signed an informed consent form. This study lasted 30 days (4 weeks), where each participant consumed daily a snack bar irradiated with UV-C. The participants were personally interviewed by the research team with a structured selection questionnaire. Thirty subjects who met the inclusion criteria were recruited, 15 of them men and 15 women. Through a simple randomization process, the participants were assigned in 3 groups of 10 people each with 5 women and 5 men, subsequently treatments (without treatment, pineapple snack bar, or mango snack bar) were randomly assigned. The outcomes between groups were analyzed with one way ANOVA, with a P-value of 0.05 or less when there was statistical significance, using statistical software. The participants, and the laboratory technicians were blinded to the treatment assignments until the conclusion of the trial.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 28 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Young adults of 18 years of age or older,
  • Healthy in appearance

Exclusion Criteria:

  • People in current medical treatment
  • Used antibiotics in past 15 days
  • Have presented infectious symptoms on previous days
  • Smokers
  • Narcotic consumers
  • Women in use of hormonal treatment
  • Contraceptives or pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: No Intervention
This group did not have an intervention
This gruop did not have an intervention
Experimental: Intervention pineapple
Daily consumption of 30 g of pineapple snack bar for 4 weeks.
30 g daily of pineapple snack bar
Experimental: Intervention mango
Daily consumption of 30 g of mango snack bar for 4 weeks.
30 g daily of mango snack bar

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change Oxygen Radical Absorbance Capacity Assay (Antioxidant Capacity)
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
Change Trolox Equivalent Antioxidant Capacity (Antioxidant Capacity)
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
Change Serum Retinol Determination
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
Change Serum pro-VA carotenoids
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change Serum total polyphenols determination
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
Change Serum cholesterol determination
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
Change Serum Triacylglycerides determination
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
Change Serum high density lipoprotein cholesterol
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
Change Body Mass Index
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
Change Body composition by fat-free mass index
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
Change Body composition by fat mass index
Time Frame: Change from baseline at thirty days
From baseline and thirty days post treatment
Change from baseline at thirty days
24-hour dietary recall
Time Frame: Baseline and thirty days
From baseline and thirty days post treatment
Baseline and thirty days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (Actual)

April 1, 2017

Study Completion (Actual)

April 1, 2017

Study Registration Dates

First Submitted

February 23, 2018

First Submitted That Met QC Criteria

April 27, 2018

First Posted (Actual)

May 11, 2018

Study Record Updates

Last Update Posted (Actual)

May 11, 2018

Last Update Submitted That Met QC Criteria

April 27, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HFAG001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

The data base will not be shared, each collaborator will participate verifying the handling of the samples and the process of analysing the results in a blinded manner.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nutritional and Metabolic Disease

Clinical Trials on No Intervention

3
Subscribe